SCID — Global X Scientific Beta Europe ETF
Data updated: 2020-09-28
SCID — Global X Scientific Beta Europe ETF. Europe Blend / Core Equity · $3.52M AUM · 0.39% expense ratio. Holdings, fees, performance and SEC filings.
SCID Fund Overview
SCID — Global X Scientific Beta Europe ETF is a US ETF managed by Global X Funds, categorised as Europe Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Global X Funds
- Category: Europe Blend / Core Equity
- Assets under management: $3.52M
- 1-year return: 0.3%
- Ticker: SCID
- SEC CIK: 0001432353
- SEC series ID: S000049484
- Share class ID: C000156406
SCID Investment Objective and Strategy
Global X Scientific Beta Europe ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Global X Funds.
Investment objective
The Global X Scientific Beta Europe ETF (Fund) seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Equal Risk Contribution Index (Underlying Index).
Principal investment strategy
"The Fund invests at least 80% of its total assets in the securities of the Underlying Index and in American Depositary Receipts (""ADRs"") and Global Depositary Receipts (""GDRs"") based on the securities in the Underlying Index. The Funds 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Underlying Index generally comprises approximately 600 or less European-listed common stocks selected based on a proprietary methodology developed by EDHEC Risk Institute Asia Ltd. (EDHEC or the Index Provider). The objective of the Underlying Index is to outperform traditional market capitalization-weighted indexes, with lower volatility. The method used by the Index Provider to seek to achieve outperformance relative to traditional market capitalization-weighted indexes is derived from a proprietary process for selecting and weighting index components from the initial universe.
The components of the Underlying Index are selected from a universe of the 600 largest, as measured by free float market capitalization, and most liquid stocks that are ordinarily traded principally on a stock exchange in one of the following 16 developed European countries: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom. The Underlying Indexs components are selected by applying four factors that have been widely recognized by academic literature to outperform market capitalization weighted-indexes over the long run: Value, Size, Low-Volatility and Momentum. Each of these factors is applied by using the following metrics: price-to-book ratio for Value; free-float market capitalization for Size; historical volatility over the trailing 104 week period for Low-Volatility; and one-year-minus-one-month total returns for Momentum.
Finally, components are weighted by the Index Provider by employing a proprietary, multi-step process that combines multiple weighting methodologies to diversify the risks associated with any one weighting scheme. For additional details on the weighting methodology, please see Information Regarding the Indices and the Index Providers . The Funds investment objective and Underlying Index may be changed without shareholder approval. The Underlying Index is sponsored by the Index Provider, which is an organization that is independent of the Fund and Global X Management Company LLC, the investment adviser for the Fund (Adviser). The Index Provider determines the relative weightings of the securities in the Underlying Index and publishes information regarding the market value of the Underlying Index.
The Adviser uses a passive or indexing approach to try to achieve the Funds investment objective. Unlike many investment companies, the Fund does not try to outperform the Underlying Index and does not seek temporary defensive positions when markets decline or appear overvalued. The Fund generally will use a replication strategy. A replication strategy is an indexing strategy that involves investing in the securities of the Underlying Index in approximately the same proportions as in the Underlying Index. However, the Fund may utilize a representative sampling strategy with respect to the Underlying Index when a replication strategy might be detrimental or disadvantageous to shareholders, such as when there are practical difficulties or substantial costs involved in compiling a portfolio of equity securities to replicate the Underlying Index, in instances in which a security in the Underlying Index becomes temporarily illiquid, unavailable or less liquid, or as a result of legal restrictions or limitations (such as tax diversification requirements) that apply to the Fund but not the Underlying Index.
The Adviser expects that, over time, the correlation between the Funds performance and that of the Underlying Index, before fees and expenses, will exceed 95%. A correlation percentage of 100% would indicate perfect correlation. If the Fund uses a replication strategy, it can be expected to have greater correlation to the Underlying Index than if it uses a representative sampling strategy. The Fund concentrates its investments (i.e . , holds 25% or more of its total assets) in a particular industry or group of industries to approximately the same extent that the Underlying Index is concentrated. As of December 29, 2017 , the Underlying Index is not concentrated in a sector."
SCID Performance
Total returns for SCID (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 0.3% |
SCID Risk Information
Risk metrics for SCID, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 24.6%
SCID Costs and Fees
SCID costs about $39 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.39%
- Gross expense ratio: 0.39%
- Portfolio turnover: 37%
- Brokerage commissions: 4.22 bps of average net assets (SEC N-CEN)
SCID Cashflows
Over the 12 months to 2020-07, Global X Scientific Beta Europe ETF had net inflows of $1.05M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2020-07 | $0 |
| 2020-06 | $1.17M |
| 2020-05 | $0 |
| 2020-04 | −$116.67K |
| 2020-03 | $0 |
| 2020-02 | $0 |
SCID Debt Constituents
No individual debt constituents are reported in Global X Scientific Beta Europe ETF's latest SEC N-PORT filing.
SCID Prospectus and SEC Filings
Official Global X Scientific Beta Europe ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2020-03-17
- Prospectus (485BPOS) — filed 2019-03-20
- Prospectus (485BPOS) — filed 2018-03-12
- Portfolio holdings (N-PORT) — filed 2020-09-28
- Portfolio holdings (N-PORT) — filed 2020-06-26
- Portfolio holdings (N-PORT) — filed 2020-03-30
- Annual census (N-CEN) — filed 2020-01-13
- Annual census (N-CEN) — filed 2019-01-14
Related Funds
Other Europe Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.